Skip to main content
OpenTrials

Clinical trial condition

Pharyngeal Neoplasms

Explore clinical trials studying Pharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

734 public trials 231 recruiting studies
Refine in advanced search Browse all conditions

Pharyngeal Neoplasms trial results

Recruiting

Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

NCT07362979

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancinoma (NPC), +12 more
Locations
  • Dongguan People's Hospital Dongguan, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Shenzhen, Guangdong, China
  • Affiliated Hospital of Guangdong Medical University Zhanjiang, Guangdong, China
View Trial Details
Recruiting

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

NCT06239727

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Dongguan People's Hospital Dongguan, Guangdong, China
  • The First People's Hospital of Foshan Foshan, Guangdong, China
View all 26 locations
View Trial Details
Recruiting

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

NCT07063212

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +29 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions